Yael Bogler, MD
Infectious Disease · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 2 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bogler’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
3 of 3 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$8,274
Medicare paid this office $8,274 for 65 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 17 | $2,564 | $75 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,927 | $107 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 23 | $1,695 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,140 | $71 |
Who their Medicare patients are
65 Original Medicare patients in 2024. Average age 69 · Under 65 29% · Women 37% · Health risk score 2.94. At or below the middle of the specialty; the typical infectious disease clinician is at 3.
Conditions among them: High blood pressure 72% · Diabetes 58% · Chronic kidney disease 45% · Heart failure 31% · Coronary heart disease 29% · Depression 28% · Atrial fibrillation 25% · Stroke 25% · Cancer 22%.
The office billed $74,699, Medicare allowed $11,140 and paid $8,274; for 114 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 65 | 114 | 69 | 2.94 | $74,699 | $8,274 |
| 2023 | 83 | 164 | 68 | 3.63 | $95,364 | $11,857 |
| 2022 | 70 | 150 | 68 | 2.67 | $89,778 | $11,840 |
| 2021 | 58 | 118 | 67 | 3.69 | $63,801 | $8,386 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Return visit (30+ min) | 16 | $3,342 | $74 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 39 | $3,251 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 19 | $1,933 | $74 |
| X-ray of chest, 1 view | 12 | $138 | $11 |
2022: 5 services
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 27 | $3,152 | $109 |
| Return visit (30+ min) | 15 | $3,090 | $77 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,485 | $113 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $1,650 | $79 |
| X-ray of chest, 1 view | 14 | $304 | $17 |
2021: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,383 | $79 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $1,247 | $104 |
Medicaid work
$71,216 in 2024
Medicaid paid $71,216 for 1,325 billed services this clinician did in 2024, up to 37 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 133 | $68,320 |
| Return visit (30+ min) | 93 | $2,353 |
| Short return visit (20+ min) | 219 | $376 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 13 | $167 |
| Pain severity quantified; no pain present (COA) (ONC) | 35 | $0 |
| Medication list documented in medical record (COA) | 246 | $0 |
| Review of all medications by a prescribing practitioner or clinical pharmacist (such as, prescriptions, OTCs, herbal therapies and supplements) documented in the medical record (COA) | 92 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 203 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 20 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 35 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 236 | $0 |
| 2024 | 1,325 | 11 | 37 | $71,216 |
| 2023 | 1,234 | 14 | 46 | $152,091 |
| 2022 | 858 | 11 | 41 | $122,812 |
| 2021 | 636 | 6 | 31 | $109,556 |
| 2020 | 99 | 2 | 24 | $29,787 |
| 2018 | 16 | 1 | 16 | $1,973 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 304 | $147,588 |
| Return visit (30+ min) | 125 | $1,680 |
| Short return visit (20+ min) | 553 | $1,054 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $657 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 26 | $442 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 32 | $285 |
| T cells; absolute CD4 and CD8 count, including ratio | 13 | $118 |
| T CELLS TOTAL COUNT | 13 | $94 |
| Short return visit | 22 | $91 |
| Radiologic examination, chest; single view | 12 | $42 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 25 | $39 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 17 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 255 | $121,042 |
| Short return visit (20+ min) | 343 | $1,171 |
| Return visit (30+ min) | 75 | $364 |
| IP/OBS CONSLTJ NEW/EST SF 35 | 15 | $108 |
| Radiologic examination, chest; single view | 12 | $83 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 14 | $34 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 15 | $10 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 18 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 43 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 56 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 229 | $106,621 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 94 | $1,441 |
| IP/OBS CONSLTJ NEW/EST PT LOW MDM 45 MINUTES | 44 | $911 |
| Short return visit (20+ min) | 216 | $583 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 37 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 64 | $29,683 |
| Short return visit (20+ min) | 35 | $104 |
2018
| Clinic visit/encounter, all-inclusive | 16 | $1,973 |
Drugs they prescribed that Part D paid
$565,061
Pharmacies billed $565,061 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
730 generic and 267 brand-name prescriptions · $565,061 in drug cost · 48 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 55 | $188,219 | $3,422 |
| Dovato | 39 | $105,063 | $2,694 |
| Odefsey | 21 | $70,619 | $3,363 |
| Tivicay | 15 | $29,966 | $1,998 |
| Pifeltro | 15 | $22,537 | $1,502 |
See all 28 drugs
| Biktarvy | 55 | $188,219 | $3,422 |
| Dovato | 39 | $105,063 | $2,694 |
| Odefsey | 21 | $70,619 | $3,363 |
| Tivicay | 15 | $29,966 | $1,998 |
| Pifeltro | 15 | $22,537 | $1,502 |
| Jardiance | 35 | $21,626 | $618 |
| Isentress | 12 | $20,898 | $1,742 |
| Rifampin | 45 | $2,128 | $47 |
| Ethambutol | 35 | $1,462 | $42 |
| Azithromycin | 20 | $878 | $44 |
| Levofloxacin | 18 | $230 | $13 |
| Atorvastatin | 91 | $200 | $2 |
| Rosuvastatin | 26 | $175 | $7 |
| Ketoconazole | 12 | $154 | $13 |
| Isoniazid | 29 | $141 | $5 |
| Famotidine | 31 | $133 | $4 |
| Bupropion Xl | 14 | $133 | $9 |
| Tamsulosin | 26 | $128 | $5 |
| Pantoprazole | 19 | $108 | $6 |
| Levetiracetam | 11 | $92 | $8 |
| Benazepril | 17 | $75 | $4 |
| Bupropion Hcl Sr | 12 | $65 | $5 |
| Gabapentin | 22 | $63 | $3 |
| Duloxetine | 14 | $56 | $4 |
| Amlodipine Besylate | 36 | $41 | $1 |
| Metformin Hcl Er | 11 | $39 | $4 |
| Finasteride | 12 | $35 | $3 |
| Carvedilol | 12 | $34 | $3 |
Year by year
| 2024 | 997 | 78 | None | 27% | $565,061 |
| 2023 | 1,629 | 122 | 1% (11) | None | $1,219,736 |
| 2022 | 1,506 | 85 | 1% (12) | 27% | $968,933 |
| 2021 | 938 | 67 | 0% (0) | 26% | $496,640 |
| 2020 | 189 | 36 | 0% (0) | 24% | $139,766 |
| 2019 | 157 | 25 | 0% (0) | 29% | $162,210 |
| 2018 | 33 | None | 0% (0) | None | $27,675 |
| 2017 | 12 | None | 0% (0) | None | $503 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 54 drugs
| Biktarvy | 124 | $534,964 | $4,314 |
| Odefsey | 33 | $115,437 | $3,498 |
| Dovato | 31 | $94,483 | $3,048 |
| Genvoya | 22 | $85,015 | $3,864 |
| Tivicay | 21 | $61,835 | $2,945 |
| Pifeltro | 25 | $57,012 | $2,280 |
| Jardiance | 35 | $27,576 | $788 |
| Isentress | 12 | $25,452 | $2,121 |
| Rifabutin | 25 | $17,255 | $690 |
| Edurant | 12 | $16,588 | $1,382 |
| Anoro Ellipta | 11 | $8,218 | $747 |
| Vascepa | 20 | $5,654 | $283 |
| Rifampin | 91 | $5,072 | $56 |
| Emtricitabine | 12 | $4,872 | $406 |
| Ethambutol | 59 | $3,403 | $58 |
| Pyrazinamide | 13 | $3,270 | $252 |
| Moxifloxacin | 18 | $3,177 | $176 |
| Lidocaine | 15 | $2,707 | $180 |
| Bupropion Xl | 29 | $1,421 | $49 |
| Atorvastatin | 107 | $1,168 | $11 |
| Levofloxacin | 28 | $1,140 | $41 |
| Divalproex Sodium Er | 11 | $819 | $74 |
| Gabapentin | 31 | $796 | $26 |
| Tamsulosin | 23 | $548 | $24 |
| Rosuvastatin | 20 | $529 | $26 |
| Azithromycin | 14 | $522 | $37 |
| Albuterol Sulfate Hfa | 12 | $496 | $41 |
| Ketoconazole | 24 | $485 | $20 |
| Carvedilol | 12 | $483 | $40 |
| Pantoprazole | 40 | $480 | $12 |
| Amlodipine Besylate | 44 | $473 | $11 |
| Acyclovir | 22 | $438 | $20 |
| Famotidine | 28 | $370 | $13 |
| Levetiracetam | 11 | $368 | $33 |
| Metformin Hcl Er | 22 | $361 | $16 |
| Duloxetine | 17 | $346 | $20 |
| Potassium Chloride | 12 | $345 | $29 |
| Benazepril | 33 | $328 | $10 |
| Isoniazid | 44 | $297 | $7 |
| Bupropion Hcl Sr | 12 | $284 | $24 |
| Ondansetron | 14 | $247 | $18 |
| Finasteride | 12 | $243 | $20 |
| Fluconazole | 15 | $228 | $15 |
| Levothyroxine | 28 | $226 | $8 |
| Metoprolol | 17 | $198 | $12 |
| Alendronate | 15 | $190 | $13 |
| Clopidogrel | 14 | $175 | $13 |
| Hydroxyzine | 11 | $169 | $15 |
| Sertraline | 13 | $161 | $12 |
| Topiramate | 12 | $125 | $10 |
| Pravastatin | 11 | $85 | $8 |
| Tramadol | 11 | $57 | $5 |
| Hydrochlorothiazide | 16 | $53 | $3 |
| Lisinopril | 11 | $40 | $4 |
2022: 51 drugs
| Biktarvy | 130 | $493,409 | $3,795 |
| Odefsey | 31 | $102,156 | $3,295 |
| Pifeltro | 32 | $53,498 | $1,672 |
| Dovato | 14 | $40,743 | $2,910 |
| Tivicay | 16 | $38,908 | $2,432 |
| Isentress | 13 | $23,997 | $1,846 |
| Jardiance | 21 | $17,867 | $851 |
| Edurant | 13 | $16,554 | $1,273 |
| Tresiba Flextouch U-200 | 13 | $8,490 | $653 |
| Pyrazinamide | 27 | $7,360 | $273 |
| Xarelto | 13 | $7,164 | $551 |
| Rifampin | 79 | $6,362 | $81 |
| Emtricitabine | 13 | $5,277 | $406 |
| Anoro Ellipta | 12 | $5,221 | $435 |
| Livalo | 12 | $3,732 | $311 |
| Ethambutol | 43 | $2,759 | $64 |
| Ondansetron | 33 | $1,667 | $51 |
| Ezetimibe | 13 | $1,423 | $109 |
| Bupropion Xl | 26 | $913 | $35 |
| Gabapentin | 25 | $903 | $36 |
| Azithromycin | 25 | $855 | $34 |
| Atorvastatin | 89 | $705 | $8 |
| Rosuvastatin | 18 | $562 | $31 |
| Amlodipine Besylate | 48 | $497 | $10 |
| Isoniazid | 63 | $430 | $7 |
| Bupropion Hcl Sr | 13 | $370 | $28 |
| Pantoprazole | 26 | $337 | $13 |
| Levothyroxine | 30 | $284 | $9 |
| Metformin Hcl Er | 29 | $276 | $10 |
| Fluconazole | 15 | $273 | $18 |
| Levetiracetam | 14 | $253 | $18 |
| Amitriptyline | 12 | $252 | $21 |
| Irbesartan-Hydrochlorothiazide | 13 | $230 | $18 |
| Ketoconazole | 14 | $214 | $15 |
| Metformin | 13 | $209 | $16 |
| Omeprazole | 12 | $208 | $17 |
| Benazepril | 25 | $183 | $7 |
| Famotidine | 11 | $173 | $16 |
| Potassium Chloride | 17 | $169 | $10 |
| Duloxetine | 11 | $161 | $15 |
| Clopidogrel | 16 | $140 | $9 |
| Metoprolol | 20 | $136 | $7 |
| Finasteride | 13 | $125 | $10 |
| Hydroxyzine | 14 | $94 | $7 |
| Tamsulosin | 17 | $88 | $5 |
| Lithium Carbonate | 12 | $85 | $7 |
| Naproxen | 11 | $80 | $7 |
| Hydrochlorothiazide | 25 | $73 | $3 |
| Sertraline | 17 | $67 | $4 |
| Alendronate | 14 | $63 | $4 |
| Fluoxetine | 12 | $50 | $4 |
2021: 25 drugs
| Biktarvy | 73 | $259,764 | $3,558 |
| Odefsey | 19 | $60,060 | $3,161 |
| Pifeltro | 16 | $24,801 | $1,550 |
| Triumeq | 16 | $21,289 | $1,331 |
| Rifampin | 60 | $3,298 | $55 |
| Ethambutol | 48 | $2,892 | $60 |
| Fluconazole | 30 | $1,663 | $55 |
| Azithromycin | 32 | $1,043 | $33 |
| Ondansetron | 12 | $586 | $49 |
| Bupropion Xl | 11 | $486 | $44 |
| Atorvastatin | 59 | $436 | $7 |
| Isoniazid | 46 | $290 | $6 |
| Levothyroxine | 19 | $239 | $13 |
| Potassium Chloride | 13 | $160 | $12 |
| Hydroxyzine | 14 | $154 | $11 |
| Gabapentin | 17 | $130 | $8 |
| Pantoprazole | 16 | $127 | $8 |
| Metformin Hcl Er | 23 | $122 | $5 |
| Irbesartan-Hydrochlorothiazide | 13 | $116 | $9 |
| Famotidine | 11 | $98 | $9 |
| Amlodipine Besylate | 14 | $91 | $7 |
| Sulfamethoxazole-Trimethoprim | 25 | $75 | $3 |
| Benazepril | 19 | $64 | $3 |
| Tamsulosin | 12 | $42 | $4 |
| Hydrochlorothiazide | 14 | $35 | $3 |
2020: 6 drugs
| Genvoya | 12 | $38,247 | $3,187 |
| Ethambutol | 18 | $936 | $52 |
| Amoxicillin-Clavulanate Potass | 14 | $845 | $60 |
| Rifampin | 19 | $693 | $36 |
| Sulfamethoxazole-Trimethoprim | 12 | $265 | $22 |
| Cefadroxil | 11 | $117 | $11 |
2019: 4 drugs
| Tivicay | 12 | $21,058 | $1,755 |
| Atazanavir Sulfate | 11 | $14,518 | $1,320 |
| Lamivudine-Zidovudine | 12 | $9,137 | $761 |
| Amoxicillin-Clavulanate Potass | 21 | $924 | $44 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1619354370
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 282N00000X (282N00000X)
- Mailing address
- 3185 S Sepulveda Blvd Apt 302, Los Angeles, CA, 90034
- NPI first listed
- 2015-05-01
- NPI last updated
- 2015-05-01
This is when the NPI record was last certified, not a medical board exam.